Genenta Science Balance Sheet Health
Financial Health criteria checks 6/6
Genenta Science has a total shareholder equity of €16.8M and total debt of €0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are €19.0M and €2.2M respectively.
Key information
0%
Debt to equity ratio
€0
Debt
| Interest coverage ratio | n/a |
| Cash | €16.91m |
| Equity | €16.82m |
| Total liabilities | €2.20m |
| Total assets | €19.02m |
Recent financial health updates
We're Keeping An Eye On Genenta Science's (NASDAQ:GNTA) Cash Burn Rate
Jan 26
We're Hopeful That Genenta Science (NASDAQ:GNTA) Will Use Its Cash Wisely
Jul 21We're Not Worried About Genenta Science's (NASDAQ:GNTA) Cash Burn
Dec 10We're Hopeful That Genenta Science (NASDAQ:GNTA) Will Use Its Cash Wisely
Sep 09Is Genenta Science (NASDAQ:GNTA) In A Good Position To Invest In Growth?
Mar 18Recent updates
We're Keeping An Eye On Genenta Science's (NASDAQ:GNTA) Cash Burn Rate
Jan 26We're Hopeful That Genenta Science (NASDAQ:GNTA) Will Use Its Cash Wisely
Jul 21We're Not Worried About Genenta Science's (NASDAQ:GNTA) Cash Burn
Dec 10We're Hopeful That Genenta Science (NASDAQ:GNTA) Will Use Its Cash Wisely
Sep 09Gene therapy developer Genenta Science named a buy at Wainwright on tumor approach
Jul 25Is Genenta Science (NASDAQ:GNTA) In A Good Position To Invest In Growth?
Mar 18Financial Position Analysis
Short Term Liabilities: GNTA's short term assets (€18.6M) exceed its short term liabilities (€2.0M).
Long Term Liabilities: GNTA's short term assets (€18.6M) exceed its long term liabilities (€204.3K).
Debt to Equity History and Analysis
Debt Level: GNTA is debt free.
Reducing Debt: GNTA has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: GNTA has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: GNTA has sufficient cash runway for 2.9 years if free cash flow continues to reduce at historical rates of 15.3% each year.